The role of the excess weight status in the risk of hospitalizations for patients with depression prescribed obesogenic antidepressants
Puzhko S, Schuster T, Renoux C, Barnett TA, Munro K, Bartlett-Esquilant G (2022)
Pharmacoepidemiology and Drug Safety 31(Suppl. 2): 424-425.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Puzhko, SvetlanaUniBi;
Schuster, Tibor;
Renoux, Christel;
Barnett, Tracie A.;
Munro, Kimberly;
Bartlett-Esquilant, Gillian
Erscheinungsjahr
2022
Serien- oder Zeitschriftentitel
Pharmacoepidemiology and Drug Safety
Band
31
Ausgabe
Suppl. 2
Seite(n)
424-425
ISSN
1053-8569
eISSN
1099-1557
Page URI
https://pub.uni-bielefeld.de/record/2966735
Zitieren
Puzhko S, Schuster T, Renoux C, Barnett TA, Munro K, Bartlett-Esquilant G. The role of the excess weight status in the risk of hospitalizations for patients with depression prescribed obesogenic antidepressants. Pharmacoepidemiology and Drug Safety . 2022;31(Suppl. 2):424-425.
Puzhko, S., Schuster, T., Renoux, C., Barnett, T. A., Munro, K., & Bartlett-Esquilant, G. (2022). The role of the excess weight status in the risk of hospitalizations for patients with depression prescribed obesogenic antidepressants. Pharmacoepidemiology and Drug Safety , 31(Suppl. 2), 424-425.
Puzhko, Svetlana, Schuster, Tibor, Renoux, Christel, Barnett, Tracie A., Munro, Kimberly, and Bartlett-Esquilant, Gillian. 2022. “The role of the excess weight status in the risk of hospitalizations for patients with depression prescribed obesogenic antidepressants”, Pharmacoepidemiology and Drug Safety , 31 (Suppl. 2): 424-425.
Puzhko, S., Schuster, T., Renoux, C., Barnett, T. A., Munro, K., and Bartlett-Esquilant, G. (2022). The role of the excess weight status in the risk of hospitalizations for patients with depression prescribed obesogenic antidepressants. Pharmacoepidemiology and Drug Safety 31, 424-425.
Puzhko, S., et al., 2022. The role of the excess weight status in the risk of hospitalizations for patients with depression prescribed obesogenic antidepressants. Pharmacoepidemiology and Drug Safety , 31(Suppl. 2), p 424-425.
S. Puzhko, et al., “The role of the excess weight status in the risk of hospitalizations for patients with depression prescribed obesogenic antidepressants”, Pharmacoepidemiology and Drug Safety , vol. 31, 2022, pp. 424-425.
Puzhko, S., Schuster, T., Renoux, C., Barnett, T.A., Munro, K., Bartlett-Esquilant, G.: The role of the excess weight status in the risk of hospitalizations for patients with depression prescribed obesogenic antidepressants. Pharmacoepidemiology and Drug Safety . 31, 424-425 (2022).
Puzhko, Svetlana, Schuster, Tibor, Renoux, Christel, Barnett, Tracie A., Munro, Kimberly, and Bartlett-Esquilant, Gillian. “The role of the excess weight status in the risk of hospitalizations for patients with depression prescribed obesogenic antidepressants”. Pharmacoepidemiology and Drug Safety 31.Suppl. 2 (2022): 424-425.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar